Strategic partnerships Qkine has active distribution and collaboration agreements with RoosterBio, Defined Bioscience, Pluristyx, and BioLife Solutions, indicating a proven channel strategy and potential for expanded OEM and supply partnerships to drive growth in cell therapy, iPSC, and regenerative medicine markets.

Expansion into cell therapy Recent product launches and positioning around cell therapy grade recombinant proteins, QkPlate coated plates, and ADSC-free GMP-like capabilities point to strong cross-sell opportunities into clinical-grade manufacturing and large-scale cell therapy workflows.

Diversified growth factors Qkine offers a broad portfolio of high-purity, animal-free growth factors and engineered proteins (e.g., optimized R-spondins), enabling up-sell to labs seeking reproducible reagents for organoid, stem cell, and regenerative medicine applications.

Geographic and academic leverage Manufacturing in Cambridge with ISO 9001:2015 certification and a research-rooted pipeline provide credibility when engaging with European and academic customers pursuing stringent quality and traceability for reproducible results.

Scale and supply certainty Bulk ordering, stock reservations, and multi-year distribution agreements with notable suppliers indicate a customer base and logistics framework conducive to recurring revenue through long-term purchasing contracts and preferred supplier programs.